Masabumi Minami Selected Research

Masabumi Minami Research Topics

Disease

24	Pain (Aches) 12/2018 - 10/2002
7	Chronic Pain 05/2024 - 01/2016
7	Neuralgia (Stump Neuralgia) 05/2024 - 10/2002
7	Brain Injuries (Brain Injury) 04/2011 - 07/2002
3	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2010
3	Hyperalgesia 01/2018 - 10/2002
3	Cocaine-Related Disorders (Cocaine Addiction) 11/2017 - 04/2014
3	Brain Ischemia (Cerebral Ischemia) 09/2011 - 07/2002
3	Brain Diseases (Brain Disorder) 04/2011 - 01/2005
3	Ischemia 04/2006 - 11/2002
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022 - 02/2004
2	Treatment-Resistant Depressive Disorder 09/2021 - 01/2017
2	Seizures (Absence Seizure) 01/2018 - 10/2002
2	Central Nervous System Diseases (CNS Diseases) 04/2011 - 01/2006
2	Visceral Pain 01/2010 - 02/2009
2	Stroke (Strokes) 05/2009 - 12/2003
2	Nociceptive Pain 02/2008 - 01/2007
2	Infarction (Infarctions) 12/2003 - 07/2002
1	Acute Pain 05/2024
1	Tobacco Use Disorder (Nicotine Dependence) 01/2022
1	Anhedonia 10/2019
1	Abdominal Pain (Pain, Abdominal) 12/2018
1	Osteoarthritis 05/2018
1	Epilepsy (Aura) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 12/2016
1	Glioma (Gliomas) 01/2012
1	Parkinson Disease (Parkinson's Disease) 09/2011

Drug/Important Bio-Agent (IBA)

7	Analgesics (Analgesic Drugs)IBA 05/2018 - 10/2002
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2021 - 11/2002
6	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2018 - 02/2008
6	ChemokinesIBA 04/2011 - 12/2003
5	Corticotropin-Releasing HormoneIBA 05/2024 - 04/2013
5	salicylhydroxamic acid (SHAM)IBA 05/2024 - 01/2016
5	Cocaine (Cocaine HCl)IBA 01/2022 - 04/2014
5	Morphine (MS Contin)FDA LinkGeneric 01/2018 - 02/2004
5	Opioid Analgesics (Opioids)IBA 08/2015 - 02/2004
5	Formaldehyde (Formol)FDA Link 04/2013 - 02/2004
4	Antidepressive Agents (Antidepressants)IBA 09/2021 - 01/2016
4	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 04/2014
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2018 - 07/2011
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2010 - 12/2003
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2020 - 11/2017
3	Glutamic Acid (Glutamate)FDA Link 01/2017 - 01/2004
3	Adenosine Triphosphate (ATP)IBA 09/2009 - 10/2002
3	Messenger RNA (mRNA)IBA 12/2003 - 10/2002
2	Nicotine FDA Link 01/2022 - 01/2012
2	Neuropeptide YIBA 01/2020 - 04/2013
2	2- methyl- 4- (N- propyl- N- cycloproanemethylamino)- 5- chloro- 6- (2,4,6- trichloranilino)pyrimidineIBA 01/2020 - 10/2019
2	Timolol (Blocadren)FDA LinkGeneric 12/2018 - 02/2008
2	LigandsIBA 05/2018 - 11/2002
2	Sucrose (Saccharose)IBA 01/2018 - 01/2016
2	Phosphates (Orthophosphate)IBA 01/2018 - 01/2016
2	Pregabalin (Lyrica)FDA Link 01/2018 - 01/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2017 - 01/2017
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2016 - 07/2008
2	Cholinergic Agents (Cholinergics)IBA 10/2016 - 04/2014
2	Opioid Receptors (Opioid Receptor)IBA 08/2015 - 09/2004
2	Fentanyl (Sublimaze)FDA LinkGeneric 12/2014 - 01/2013
2	Peptides (Polypeptides)IBA 04/2013 - 01/2005
2	CytokinesIBA 04/2011 - 01/2006
2	CC ChemokinesIBA 04/2010 - 12/2003
2	Acetic Acid (Vinegar)FDA LinkGeneric 02/2009 - 01/2007
2	Chemokine ReceptorsIBA 12/2003 - 07/2002
1	MecamylamineIBA 01/2022
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2022
1	Ketamine FDA LinkGeneric 09/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	LipidsIBA 01/2021
1	resolvin D2IBA 01/2021
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2021
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2018
1	AcidsIBA 05/2018
1	5,6-epoxy-8,11,14-eicosatrienoic acidIBA 05/2018
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 05/2018
1	glycocyamineIBA 01/2018
1	CreatineIBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2017
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2017
1	Escitalopram FDA Link 01/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2016
1	adenosine-3',5'-cyclic phosphorothioateIBA 12/2016
1	Cyclic AMP (AMP, Cyclic)IBA 12/2016
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2016
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 12/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2016
1	SolutionsIBA 01/2016
1	Tramadol (K315)FDA LinkGeneric 08/2015
1	Serotonin (5 Hydroxytryptamine)IBA 08/2015
1	Purinergic P2X7 ReceptorsIBA 12/2014
1	CRF receptor type 2IBA 04/2013
1	SmokeIBA 01/2012
1	Clonidine (ST 155)FDA LinkGeneric 07/2011
1	N-Methylaspartate (NMDA)IBA 04/2010

Therapy/Procedure

6	Injections 01/2020 - 01/2007
4	Ligation 10/2019 - 04/2004
2	Spinal Injections 01/2018 - 01/2016
2	Therapeutics 04/2011 - 01/2006
1	Meniscectomy 05/2018
1	Glycemic Control 12/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2011